Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score N/A
- Piotroski Score N/A
- Grade Perform
- Symbol (AYLA)
- Company Ayala Pharmaceuticals, Inc.
- Price $0.53
- Changes Percentage (0%)
- Change -$0
- Day Low $0.44
- Day High $0.57
- Year High $5.94
Ayala Pharmaceuticals, Inc., a clinical-stage oncology company, focuses on developing and commercializing small molecule therapeutics for patients suffering from rare and aggressive cancers. The company's lead product candidate is AL101, a potent, selective, and injectable small molecule gamma secretase inhibitor (GSI) that is in Phase II clinical trial for the treatment of recurrent/metastatic adenoid cystic carcinoma for patients bearing Notch-activating mutations. It is also involved in developing AL102, a potent, selective, and oral small molecule GSI that is in Phase II/III pivotal study for the treatment of desmoid tumors. Ayala Pharmaceuticals, Inc. has a collaboration agreement with Novartis International Pharmaceutical Limited to develop AL102 for the treatment of multiple myeloma. The company was incorporated in 2017 and is headquartered in Rehovot, Israel.
- Last Earnings
- Ex-Dividend for 5/16 Dividend
- Dividend Payable
- Today N/A
- Next Earnings (Estimated) 03/27/2023
- Fiscal Year End N/A
- Average Stock Price Target $0.00
- High Stock Price Target $0.00
- Low Stock Price Target $0.00
- Potential Upside/Downside N/A
- Consensus Rating Neutral
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) $0.00
- Trailing P/E Ratio 0
- Forward P/E Ratio 0
- P/E Growth 0
- Net Income $-38,013,000
Income Statement
Quarterly
Annual
Latest News of AYLA
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Lynx beat the Dream 76-64 as Kayla McBride scores 12 of her 15 points in the third quarter
Kayla McBride scored 12 of her 15 points in the third quarter, leading the Minnesota Lynx to a 76-64 victory over the Atlanta Dream. Bridget Carleton contributed 14 points, helping Minnesota secure th...
By CBS News | 2 weeks ago -
Kayla McBride scores 12 of her 15 points in the third quarter, and the Lynx beat the Dream 76-64
Kayla McBride led the Minnesota Lynx to a 76-64 victory over the Atlanta Dream, scoring 12 of her 15 points in the third quarter....
By AP NEWS | 2 weeks ago -
Kayla McBride scores 19 to help Lynx beat Mercury 89-76, extend win streak to 7 games
Kayla McBride led Minnesota Lynx to victory over Phoenix Mercury with 19 points and 3 three-pointers. Lynx extended their winning streak to seven games, securing the second-best record in the WNBA. Di...
By AP NEWS | 1 month ago